{"id":"aav-cngb3","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL5396470","moleculeType":null,"molecularWeight":"393.40"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"AAV-mediated gene therapy aims to restore vision in patients with inherited retinal diseases by delivering a healthy copy of the CNGB3 gene to the retina.","oneSentence":"Gene therapy targeting the CNGB3 gene","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:51:24.421Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Leber congenital amaurosis"},{"name":"Retinitis pigmentosa"}]},"trialDetails":[{"nctId":"NCT03278873","phase":"","title":"Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3","status":"TERMINATED","sponsor":"MeiraGTx UK II Ltd","startDate":"2017-06-29","conditions":"Achromatopsia","enrollment":34},{"nctId":"NCT03001310","phase":"PHASE1, PHASE2","title":"Gene Therapy for Achromatopsia (CNGB3)","status":"COMPLETED","sponsor":"MeiraGTx UK II Ltd","startDate":"2017-01-16","conditions":"Achromatopsia","enrollment":23},{"nctId":"NCT02599922","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beacon Therapeutics","startDate":"2016-04-11","conditions":"Achromatopsia","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"AAV - CNGB3","genericName":"AAV - CNGB3","companyName":"MeiraGTx UK II Ltd","companyId":"meiragtx-uk-ii-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Gene therapy targeting the CNGB3 gene Used for Leber congenital amaurosis, Retinitis pigmentosa.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}